|
 EPI
UPDATE
A weekly publication by the Bureau of Epidemiology
For November 19, 1999
"The reason for collecting, analyzing and disseminating information on a disease
is to control that disease. Collection and analysis should not be allowed to consume
resources if action does not follow."
--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.
Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Jill H. Parker, MSP, Epi Update Editor
Bureau of Epidemiology Frequent Contributors:
Steven
Wiersma, MD, MPH,
Deputy State Epidemiologist |
William
J. Bigler, PhD, MS,
Senior Epidemiologist |
Jodi
Baldy, MPH,
Biological Scientist IV |
Ursula
E. Bauer, PhD,
Chronic Disease Epidemiologist |
John
Werth, MA,
Bureau Education Coordinator |
Lisa
Conti, DVM, MPH,
State Public Health Veterinarian |
Regional Epidemiologists:
Dolly Katz,
PhD, MPH,
SE Florida |
Roger
Sanderson, RN, MA,
SW Florida |
Carina Blackmore, MS Vet. Med.,
PhD, NE Florida Carina Blackmore, MS Vet. Med., PhD, |
Zuber Mulla, MSPH, Central
Florida Carina Blackmore, MS Vet. Med., PhD, |
Gérard Krause,
MD, DTMH,
NW Florida |
Please print out this material and share with epidemiology staff,
county health department directors, administrators, medical directors, nursing directors,
environmental health directors and others with an interest in information of this type.
Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7 days
a week for consultation at our main number (850/245-4401) PLEASE NOTE:
Consultation after 5 p.m. & on weekends is intended for emergencies.
In this issue:
1. Florida Influenza Surveillance Program Summary Update: Week 44 (Week
Ending 11/06/99)
2. Florida Respiratory Syncytial Virus (RSV) Surveillance Program Update:
October 15, 1999 through November 12, 1999
3. CDC Vibrio Surveillance System Summary Data, 1997-1998
4. Bureau of Epidemiology Employment Opportunity for Perinatal
Epidemiologist
5. Weekly Disease Table: Week 45
1. Florida Influenza Surveillance Program
Summary Update: Week 44 (week ending 11/06/99)
Carina Blackmore, MS Vet Med. PhD
National:
Since October 3, 1999, laboratory confirmed influenza A virus
infections were reported from 30 states. Influenza B was reported from 3 states. Both
influenza A and B were isolated in Florida during this time period. Indiana and New York
State reported regional influenza activity as assessed by state and territorial
epidemiologists, and thirty-six other states reported sporadic influenza activity.
Of the total patient visits to sentinel physicians, 1% were due to ILI
(influenza-like-illness) in the U.S. overall. The percentages were within baseline levels
(0%-3%) in 8 of the 9 regions. Influenza-like illness were seen in 5% of the patients of
sentinel physicians in the West South Central region 5%. The percentage of pneumonia and
influenza deaths reported from the 122 cities was 7.4% for week 44, which is above the
epidemic threshold of 6.5%. This is the seventh consecutive week the percentage of
pneumonia and influenza deaths have exceeded the baseline limits for this time of year. It
is unclear whether this increase in the percentage of deaths due to pneumonia and
influenza is due to early influenza activity, respiratory illness due to some other
pathogen, or reporting changes underway in the 122 Cities Mortality Reporting System.
Florida:
During week 44 (31 October-6 November 1999) laboratory confirmed isolates of
influenza A H3N2/Sydney-like were reported from Broward, Miami-Dade and Palm Beach
Counties. Influenza A has also been isolated from Alachua, Brevard, Collier (A H3N2),
Duval, Hillsborough, Indian River (A H3N2), Leon (A H3N2) and Orange Counties since
October 1, 1999. Influenza B/Yamanashi-like has been isolated from Indian River County.
Antigens from both influenza A/Sydney and influenza B/Yamanashi are included in the
1999-2000 influenza vaccine. Of the total patient visits to sentinel physicians for Week
44, 1% were due to ILI, which is slightly lower than the influenza activity reported for
the 4 previous weeks (2%) but within the expected range of 0-3%. So far this season,
influenza-like illness has been reported from 45 health care providers in 22 counties
statewide.
2. Florida Respiratory Syncytial Virus (RSV) Surveillance Program
Update: October 15, 1999 through November 12, 1999
Jill H. Parker, MSP and Laurence Burnsed, FAMU MPH Candidate,
Bureau of Epidemiology

The Bureau of Epidemiology began data collection for the Florida RSV Surveillance
Program on October 15, 1999. Thirteen hospitals have actively participated in data
collection, providing weekly counts of the total number of RSV tests performed and the
total number of those tests that yielded a positive result (either through screening tests
or cultures). A graph of the percent of positive RSV tests by week and region for weeks
1-5 (October 15 - November 12) of data collection is included below.
According to the Centers for Disease Control and Prevention, periods of RSV infection
are considered to be epidemic when laboratories report at least 2 consecutive weeks when
more than 10 percent of all specimens are tested positive. From July 1990 through June
1998, peak activity has been recorded primarily in temperate climates, beginning in
November and continuing for an average of 22 weeks (range of 20 26 weeks) to April
or mid-May.
Data collected during the first five weeks of the Florida RSV Surveillance Program
indicate the percent of positive RSV tests have consistently remained above 10 percent,
with the exception of week 4 data in the Northern region. These data illustrate possible
peak activities occurring in Florida that are consistent with national trends.
Additional graphs may be accessed from the Bureau of Epidemiology web site at
www.doh.state.fl.us (choose epidemiology, then scroll down to "FL Respiratory
Syncytial Virus").
3. CDC Vibrio Surveillance System, Summary Data,
1997-1998
(The following information was excerpted from a memorandum dated October 4,1999 from
the Foodborne and Diarrheal Diseases Branch, Division of Bacterial and Mycotic Diseases,
National Center for Infectious Diseases, the Centers for Disease Control regarding the
Vibrio Surveillance System)
Since 1988, the Centers for Disease Control has maintained a voluntary Vibrio
Surveillance System for culture-confirmed Vibrio infections in the Gulf Coast states
(Note: In recent years, additional states have been invited to participate and
surveillance has expanded to include both the East and West coasts). Using a standardized
form, investigators obtain clinical data, information about underlying illness, and
epidemiologic data on seafood consumption and exposure to seawater in the week before
illness. When a food item is implicated in illness, a traceback investigation is performed
by state field investigators or the U.S. Food and Drug Administration (FDA). Surveillance
data have been used to identify environmental risk factors, retail food outlets where
high-risk exposure occur, and target groups that may benefit from consumer education.
- Three outbreaks of V. parahaemolyticus infections linked to the consumption of
raw oysters occurred in 1997 and 1998. The first occurred in July and August 1997, and
involved 209 culture-confirmed cases in persons who consumed raw oysters harvested from
the coasts of California, Oregon, Washington, and British Columbia [MMWR Vol. 47 No.22].
In the summer of 1988, 416 persons developed diarrhea after consuming oysters harvested
from Galveston Bay, Texas; 110 of these had culture-confirmed V. parahaemolyticus
infection. Between July and September 1988, 23 culture- confirmed cases of V.
parahaemolyticus infections were identified among persons who had consumed oysters and
clams harvested from Long Island Sound [MMWR Vol. 48 No. 3].
- A total of 937 cases of culture-confirmed Vibrio illnesses were reported to the Vibrio
Surveillance System in 1997 and 1998, 389 from 5 Gulf Coast states (Alabama, Florida,
Louisiana, Mississippi, and Texas) and 548 from 26 other states and one territory. Among
those about whom this information was available, 300 (37%) of 809 were hospitalized and 46
(7%) of 707 died. Although V. parahaemolyticus was the most frequently reported Vibrio
species, V. vulnificus accounted for 41 (89%) of the 46 reported deaths.
- 92% of the Vibrio infections could be categorized into one of three
well-recognized syndromes:
- 75% (646 cases) were classified as gastroenteritis, defined as an illness with diarrhea,
vomiting, or abdominal cramps, no evidence of a wound infection, and Vibrio spp
isolated from stool alone.
- 16% (135 cases) were classifed as wound infections, in which the patient incurred a
wound before or during exposure to seawater or seafood drippings, and Vibrio spp
was subsequently cultured from the blood, wound or a normally sterile site.
- 9% (77 cases ) were classified as septicemia, characterized by fever or shock in which Vibrio
spp was isolated from the blood or normally sterile site, and no evidence of a wound
infection
- Vibrio
infections were seasonal; 417 (65%) of gastroenteritis cases occurred between
June and August, 87 (64%) of wound infections occurred between May and August, and 72
(94%) of septicemic infections occurred between May and November.
- Among illnesses with one Vibrio species in which the species was determined, V.
parahaemolyticus accounted for 473 (75%) of the gastrointestinal illnesses, while V.
vulnificus was isolated in 64 (51%) of wound infections and 62 (82%) of septicemia
cases.
- 569 (92%) of 616 persons with gastroenteritis or septicemia consumed seafood in the 7
days before their illness onset. Of the 278 (49%) of these who consumed a single seafood,
190 (68%) ate oysters, and 173 (97%) of the 179 persons who provided the information
consumed their oysters raw.
4. Bureau of Epidemiology Employment Opportunity for Perinatal
Epidemiologist
Dan Thompson, MPH, Program Administrator, Bureau of Epidemiology
We currently have an anticipated opening in the Chronic Disease Section of the Bureau
of Epidemiology. The position class title is Health Services and Facilities Consultant,
and most of the work involves perinatal epidemiology. The pay grade is 24 with a minimum
annual salary of $35,831. This position is currently held by Chrissy Gest who will be
taking another job after 11/26/99.
Good candidates for this position are persons with experience working with large data
sets and programming in SPSS, SAS or similar software, and experience in perinatal
epidemiology and statistics. Also important is the inclination and ability to write up the
results of the work.
5. Weekly Disease Table: Week 45
County-Confirmed Cases, Sorted Alphabetically by Disease
(NR represents years that the disease lacked status as a reportable condition)
DISEASE |
1996 TO DATE |
1997 TO DATE |
1998 TO DATE |
3 YEAR AVERAGE
TO DATE |
1998 TOTAL CASES |
1999 TO DATE |
| Amebiasis |
65 |
48 |
59 |
57.3 |
91 |
46 |
| Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
| Botulism |
0 |
0 |
0 |
0 |
0 |
3 |
| Brucellosis |
5 |
0 |
3 |
2.7 |
3 |
2 |
| Campylobacteriosis |
999 |
866 |
709 |
858 |
975 |
750 |
| Ciguatera |
12 |
9 |
7 |
9.3 |
7 |
2 |
| Cryptosporidiosis |
289 |
139 |
138 |
188.7 |
203 |
135 |
| Cyclosporiasis |
185 |
65 |
6 |
85.3 |
6 |
4 |
| Dengue |
0 |
3 |
5 |
2.7 |
5 |
4 |
| Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
| E. coli O157:H7 |
31 |
44 |
41 |
38.7 |
57 |
50 |
| E. coli, other (known serotype) |
7 |
6 |
6 |
6.3 |
12 |
13 |
| Ehrlichiosis, Human |
4 |
2 |
0 |
2 |
1 |
1 |
| Encephalitis, Eastern Equine |
1 |
2 |
0 |
1 |
0 |
2 |
| Encephalitis, St. Louis |
0 |
8 |
1 |
3 |
2 |
2 |
| Encephalitis, other (known organism) |
5 |
13 |
6 |
8 |
7 |
3 |
| Encephalitis, post-infectious1 |
15 |
10 |
15 |
13.3 |
21 |
6 |
| Giardiasis (acute) |
1742 |
1453 |
1259 |
1484.7 |
1636 |
1005 |
| Haemophilus influenzae, invasive1 |
19 |
23 |
32 |
24.7 |
45 |
38 |
| Hansens Disease (Leprosy) |
2 |
0 |
4 |
2 |
4 |
3 |
| Hantavirus Infection |
0 |
0 |
0 |
0 |
0 |
0 |
| Hemolytic Uremic Syndrome |
1 |
5 |
11 |
5.7 |
12 |
7 |
| Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
| Hepatitis A |
429 |
473 |
445 |
449 |
538 |
576 |
| Hepatitis B |
435 |
323 |
346 |
368 |
466 |
357 |
| Hepatitis C2 |
NR |
NR |
NR |
NR |
NR |
46 |
| Hepatitis Non-A, Non-B |
73 |
83 |
76 |
77.3 |
94 |
12 |
| Hepatitis, perinatal B2 |
NR |
NR |
NR |
NR |
NR |
2 |
| Hepatitis, unspecified |
3 |
7 |
19 |
9.7 |
27 |
11 |
| Hepatitis, +HBsAg, pregnant woman2 |
NR |
NR |
NR |
NR |
NR |
53 |
| Lead Poisoning |
1812 |
1267 |
1542 |
1540.3 |
1805 |
645 |
| Legionellosis |
32 |
22 |
31 |
28.3 |
48 |
23 |
| Leptospirosis |
1 |
0 |
1 |
0.7 |
2 |
1 |
| Listeriosis2 |
NR |
NR |
NR |
NR |
NR |
23 |
| Lyme Disease |
25 |
32 |
43 |
33.3 |
71 |
34 |
| Malaria |
70 |
66 |
64 |
66.7 |
96 |
71 |
| Measles |
1 |
6 |
2 |
3 |
2 |
2 |
| Meningococcal Disease (N. meningitidis) |
157 |
129 |
106 |
130.7 |
133 |
95 |
| Meningitis, Group B Streptococci |
23 |
14 |
15 |
17.3 |
22 |
13 |
| Meningitis, Haemophilus influenzae1 |
7 |
11 |
11 |
9.7 |
12 |
12 |
| Meningitis, Streptococcus pneumoniae |
84 |
69 |
71 |
74.7 |
96 |
80 |
| Meningitis, Listeria monocytogenes |
6 |
3 |
5 |
4.7 |
13 |
7 |
| Meningitis, other bacterial (including
unspecified) |
86 |
55 |
51 |
64 |
75 |
55 |
| Mercury Poisoning |
6 |
2 |
0 |
2.7 |
4 |
4 |
| Mumps |
9 |
10 |
11 |
10 |
11 |
4 |
| Neurotoxic Shellfish Poisoning2 |
3 |
0 |
0 |
1 |
0 |
0 |
| Pertussis |
83 |
56 |
35 |
58 |
39 |
67 |
| Pesticide Poisoning |
1 |
0 |
1 |
0.7 |
1 |
32 |
| Plague |
0 |
0 |
0 |
0 |
0 |
0 |
| Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
| Psittacosis |
0 |
0 |
2 |
0.7 |
2 |
0 |
| Rabies, Animal |
217 |
244 |
182 |
214.3 |
215 |
171 |
| Rocky Mountain Spotted Fever |
2 |
3 |
2 |
2.3 |
2 |
1 |
| Rubella, including congenital |
10 |
3 |
4 |
5.7 |
4 |
0 |
| Salmonellosis |
2198 |
1947 |
2338 |
2161 |
3038 |
2300 |
| Shigellosis |
1360 |
1272 |
1874 |
1502 |
2343 |
1159 |
| Smallpox2 |
NR |
NR |
NR |
NR |
NR |
0 |
| Staphlococcus aureus, (GISA/VISA)2 |
NR |
NR |
NR |
NR |
NR |
0 |
| Staphlococcus aureus, (GRSA/VRSA)2 |
NR |
NR |
NR |
NR |
NR |
0 |
| Streptococcal Disease, invasive Group A |
6 |
31 |
37 |
24.7 |
57 |
66 |
| Streptococcus pneumoniae, invasive
disease |
20 |
178 |
345 |
181 |
493 |
506 |
| Tetanus |
3 |
1 |
3 |
2.3 |
3 |
2 |
| Toxic Shock Syndrome |
0 |
2 |
4 |
2 |
4 |
5 |
| Toxoplasmosis |
8 |
6 |
11 |
8.3 |
15 |
13 |
| Typhoid Fever |
22 |
12 |
13 |
15.7 |
16 |
23 |
| Vibrio cholerae (serogrp O1) |
0 |
0 |
0 |
0 |
0 |
1 |
| Vibrio cholerae (serogrp Non-O1) |
3 |
10 |
6 |
6.3 |
11 |
8 |
| Vibrio vulnificus |
17 |
15 |
27 |
19.7 |
35 |
20 |
| Vibrio other (including unspecified) |
19 |
24 |
58 |
33.7 |
73 |
35 |
| Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |
1 Haemophilus influenzae can be the agent responsible for disease under
three of the reportable conditions listed-: "Haemophilus influenzae,
invasive" and under "Encephalitis, post infectious." Cases of Haemophilus
influenzae meningitis are reported under "Meningitis, H. influenzae."
2 The reportable disease rule was revised in July, 1999. Kawasaki Disease,
Histoplasmosis, Reye Syndrome, and Typhus were deleted from the weekly disease table since
cases are no longer reportable as of July 4, 1999. Hepatitis C; perinatal hepatitis B;
hepatitis B +HbsAg, pregnant woman; listeriosis; smallpox, S. aureus (GISA/VISA)
and S. aureus (GRSA/VRSA) were added to the reporting requirements as of July 4,
1999. Paralytic shellfish poisoning is now referred to as neurotoxic shellfish poisoning.
|